Karyopharm Therapeutics | KPTI - Modal Saham Biasa





Modal Saham Biasa Perubahan Tanggal
AbbVie USD 1.77B 608K 2026-06
Abbott USD 1.74B 2.94M 2026-03
Amgen USD 541M 0 2026-09
AstraZeneca USD 1.55B 28K 2026-09
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Enanta Pharmaceuticals USD 212K 1000 2023-12
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Incyte USD 200.98M 1.03M 2026-06
J&J USD 2.41B 1.64M 2026-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
MacroGenics USD 63.65M 86K 2026-06
Merck USD 2.47B 1.05M 2026-06
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novartis USD 1.89B 12.09M 2026-09
Novartis USD 1.89B 19.47M 2026-09
Pfizer USD 5.7B 0 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Takeda JPY 1.58B 460K 2026-06
Tectonic Therapeutic USD 19.24M 404.78K 2026-06
TG Therapeutics USD 153.08M 2.23M 2026-06
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
Xencor USD 74.33M 265K 2026-06